# Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

> **NCT04175626** · — · COMPLETED · sponsor: **Biotronik, Inc.** · enrollment: 556 (actual)

## Conditions studied

- Coronary Artery Disease
- Atherosclerosis, Coronary
- Myocardial Ischemia
- Ischemic Heart Disease
- Acute Coronary Syndrome
- Angina Pectoris

## Interventions

- **DEVICE:** Orsiro DES

## Key facts

- **NCT ID:** NCT04175626
- **Lead sponsor:** Biotronik, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-24
- **Primary completion:** 2022-01-12
- **Final completion:** 2026-01-08
- **Target enrollment:** 556 (ACTUAL)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04175626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04175626, "Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04175626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*